Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis
about
Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveatsHow efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysisAssessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data.Non-stimulant treatments for ADHD.Non-stimulant treatment for attention deficit hyperactivity disorder.Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies.Beyond methylphenidate: nonstimulant medications for youth with ADHD.Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients?Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry.Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy.EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses.Heterogeneity in the pharmacological treatment of children with ADHD: cognitive, behavioral, and social functioning differences.Psychotropic drug prescribing in child and adolescent learning disability psychiatry.
P2860
Q28138163-2A2F1F92-E1AA-4A4C-8BDF-9C87B99040B0Q28344196-3E351CA9-471A-4483-B149-EF2776B15361Q31143254-E4B4B60B-C14E-4743-8E19-3154BDC255C6Q34120068-F05305B8-4FC0-4E0F-BC53-75FF362CC9C0Q34396669-A7D68D60-F651-4925-96B4-AD13CAD55654Q34651712-D62ED1D6-3A40-41D6-9065-87E11CEA23E4Q36968906-A5EBAF68-9090-4036-98AA-6380A5A2B45AQ37413774-EFFABB25-F050-477E-A196-D10D752C9D2CQ38626082-E7F166E3-1743-4828-A90E-BC4F8EFE2DDFQ42736779-36527D57-4DE6-4AD7-ABDB-19E05DE67028Q48068505-1502CF56-0262-4F3E-9157-71F5094EC13FQ50140142-CE5F33E3-E7CE-473E-828A-4C3BBC23C28AQ51052520-11FEFEA3-6C62-40FC-BB6E-16296501DDFDQ51904705-E6D0F215-504C-4F69-9AE1-DC601681AB2E
P2860
Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Carbamazepine use in children ...... vity disorder: a meta-analysis
@ast
Carbamazepine use in children ...... vity disorder: a meta-analysis
@en
Carbamazepine use in children ...... vity disorder: a meta-analysis
@nl
type
label
Carbamazepine use in children ...... vity disorder: a meta-analysis
@ast
Carbamazepine use in children ...... vity disorder: a meta-analysis
@en
Carbamazepine use in children ...... vity disorder: a meta-analysis
@nl
prefLabel
Carbamazepine use in children ...... vity disorder: a meta-analysis
@ast
Carbamazepine use in children ...... vity disorder: a meta-analysis
@en
Carbamazepine use in children ...... vity disorder: a meta-analysis
@nl
P2093
P921
P1476
Carbamazepine use in children ...... vity disorder: a meta-analysis
@en
P2093
P356
10.1097/00004583-199603000-00017
P407
P577
1996-03-01T00:00:00Z